Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1995;73(4):431–435.

Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting.

PMCID: PMC2486787  PMID: 7554013

Abstract

Influenza has been a significant public health problem worldwide, with three pandemics during the past century. Immunization is the most effective measure to control an influenza pandemic. Since rapid production of large amounts of influenza vaccine depends on the availability of fertile hens' eggs to grow the viruses, there is an urgent need for the development of alternative cell culture systems, which would allow rapid scale-up of production in the event of a pandemic. This WHO meeting discussed the results of studies from several laboratories on the cultivation of influenza viruses in stable cell lines, and made recommendations for further work.

Full text

PDF
431

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baez M., Palese P., Kilbourne E. D. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis. 1980 Mar;141(3):362–365. doi: 10.1093/infdis/141.3.362. [DOI] [PubMed] [Google Scholar]
  2. Boycott R., Klenk H. D., Ohuchi M. Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. Virology. 1994 Sep;203(2):313–319. doi: 10.1006/viro.1994.1489. [DOI] [PubMed] [Google Scholar]
  3. CHANG R. S. Genetic study of human cells in vitro. Carbohydrate variants from cultures of HeLa and conjunctival cells. J Exp Med. 1960 Feb 1;111:235–254. doi: 10.1084/jem.111.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kaverin N. V., Webster R. G. Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. J Virol. 1995 Apr;69(4):2700–2703. doi: 10.1128/jvi.69.4.2700-2703.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Merten O. W., Kierulff J. V., Castignolles N., Perrin P. Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines. Cytotechnology. 1994;14(1):47–59. doi: 10.1007/BF00772195. [DOI] [PubMed] [Google Scholar]
  6. Rocha E. P., Xu X., Hall H. E., Allen J. R., Regnery H. L., Cox N. J. Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. J Gen Virol. 1993 Nov;74(Pt 11):2513–2518. doi: 10.1099/0022-1317-74-11-2513. [DOI] [PubMed] [Google Scholar]
  7. SUGIURA A., KILBOURNE E. D. GENETIC STUDIES OF INFLUENZA VIRUSES. II. PLAQUE FORMATION BY INFLUENZA VIRUSES IN A CLONE OF A VARIANT HUMAN HETEROPLOID CELL LINE. Virology. 1965 Jul;26:478–488. doi: 10.1016/0042-6822(65)90010-3. [DOI] [PubMed] [Google Scholar]
  8. Tanaka T., Urabe M., Goto H., Tobita K. Isolation and preliminary characterization of a highly cytolytic influenza B virus variant with an aberrant NS gene. Virology. 1984 Jun;135(2):515–523. doi: 10.1016/0042-6822(84)90205-8. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES